Table 4 Complications and adverse effects after magnetic resonance-guided high-intensity focused ultrasound ablation for groups 1 and 2
Complications | All patients (n = 76) | Group 1 (n = 21) | Group 2 (n = 55) | P value |
|---|---|---|---|---|
Minor | ||||
Skin burn grade 1 | 3 (3.9%) | 2 (9.5%) | 1 (1.8%) | 0.183 |
Skin burn grade 2 | 1 (1.3%) | 0 | 1 (1.8%) | 1.000 |
Abnormally increased SI in the subcutaneous fat layer | 21 (27.6%) | 6 (28.6%) | 15 (27.3%) | 1.000 |
Back pain | 4 (5.3%) | 1 (4.5%) | 3 (5.4%) | 1.000 |
Buttock pain | 10 (13.1%) | 2 (9.5%) | 8 (14.5%) | 0.717 |
Cystitis | 1 (1.3%) | 1 (4.5%) | 0 | 0.276 |
Nausea | 5 (6.6%) | 1 (4.5%) | 4 (7.3%) | 1.000 |
Numbness foot | 4 (5.3%) | 0 | 4 (7.3%) | 0.571 |
Vaginal discharge | 6 (7.9%) | 1 (4.5%) | 5 (9.1%) | 1.000 |
Pelvic pain | 6 (7.9%) | 2 (9.5%) | 4 (7.3%) | 0.666 |
Leg pain | 4 (5.3%) | 0 | 4 (7.3%) | 0.571 |
Heating sensation | 13 (17.1%) | 4 (19%) | 9 (16.4%) | 0.745 |
Major | 0 | 0 | 0 | NA |